Article (Scientific journals)
Heart 6-phosphofructo-2-kinase activation by insulin requires PKB (protein kinase B), but not SGK3 (serum- and glucocorticoid-induced protein kinase 3).
Mouton, Veronique; Toussaint, Louise; Vertommen, Didier et al.
2010In Biochemical Journal, 431 (2), p. 267-75
Peer Reviewed verified by ORBi
 

Files


Full Text
BiochemJ 2010.pdf
Publisher postprint (780.11 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Animals; Binding Sites; Cattle; Cell Line; Enzyme Activation/drug effects; Humans; Insulin/pharmacology; Male; Mice; Mice, Transgenic; Mutation/genetics; Myocardium/cytology/enzymology; Myocytes, Cardiac/drug effects/enzymology; Organ Specificity/drug effects; Phosphofructokinase-2/metabolism; Protein Kinase Inhibitors/pharmacology; Protein-Serine-Threonine Kinases/metabolism; Proto-Oncogene Proteins c-akt/antagonists & inhibitors/deficiency/metabolism; Rats; Rats, Wistar; Substrate Specificity/drug effects
Abstract :
[en] On the basis of transfection experiments using a dominant-negative approach, our previous studies suggested that PKB (protein kinase B) was not involved in heart PFK-2 (6-phosphofructo2-kinase) activation by insulin. Therefore we first tested whether SGK3 (serum- and glucocorticoid-induced protein kinase 3) might be involved in this effect. Treatment of recombinant heart PFK-2 with [gamma-32P]ATP and SGK3 in vitro led to PFK-2 activation and phosphorylation at Ser466 and Ser483. However, in HEK-293T cells [HEK (human embryonic kidney)-293 cells expressing the large T-antigen of SV40 (simian virus 40)] co-transfected with SGK3 siRNA (small interfering RNA) and heart PFK-2, insulin-induced heart PFK-2 activation was unaffected. The involvement of PKB in heart PFK-2 activation by insulin was re-evaluated using different models: (i) hearts from transgenic mice with a muscle/heart-specific mutation in the PDK1 (phosphoinositide-dependent protein kinase 1)-substrate-docking site injected with insulin; (ii) hearts from PKBbeta-deficient mice injected with insulin; (iii) freshly isolated rat cardiomyocytes and perfused hearts treated with the selective Akti-1/2 PKB inhibitor prior to insulin treatment; and (iv) HEK-293T cells co-transfected with heart PFK-2, and PKBalpha/beta siRNA or PKBalpha siRNA, incubated with insulin. Together, the results indicated that SGK3 is not required for insulin-induced PFK-2 activation and that this effect is likely mediated by PKBalpha.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Mouton, Veronique
Toussaint, Louise ;  Université de Liège - ULiège > Chimie et bio-industries > Centre de Bio. Fond. - Section de Biologie cell. et moléc.
Vertommen, Didier
Gueuning, Marie-Agnes
Maisin, Liliane
Havaux, Xavier
Sanchez-Canedo, Cossette
Bertrand, Luc
Dequiedt, Franck  ;  Université de Liège - ULiège > GIGA-Research - Centre de Bio. Fond. - Section de Biologie cell. et moléc.
Hemmings, Brian A
Hue, Louis
Rider, Mark H
Language :
English
Title :
Heart 6-phosphofructo-2-kinase activation by insulin requires PKB (protein kinase B), but not SGK3 (serum- and glucocorticoid-induced protein kinase 3).
Publication date :
2010
Journal title :
Biochemical Journal
ISSN :
0264-6021
eISSN :
1470-8728
Publisher :
Portland Press, London, United Kingdom
Volume :
431
Issue :
2
Pages :
267-75
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 29 November 2010

Statistics


Number of views
126 (2 by ULiège)
Number of downloads
240 (0 by ULiège)

Scopus citations®
 
24
Scopus citations®
without self-citations
18
OpenCitations
 
23

Bibliography


Similar publications



Contact ORBi